Cell and Gene Therapy Shows Early Promise Against Alzheimer’s—But Challenges Remain

Longeveron and Lexeo Therapeutics are working on CGT therapies to treat Alzheimer’s disease, but it’s not clear whether they have a better chance of success than traditional approaches.